Now that MoCRA has granted the FDA the authority to assess the safety of PFAS in cosmetics, the primary jurisdiction doctrine may apply to dismiss such lawsuits pending FDA’s determination.

MOCRA includes authorization of appropriations for fiscal years 2023 through 2027 for carrying out the new and existing provisions relating to cosmetics.

The cosmetic industry is preparing for yet another rapidly approaching deadline imposed by the Modernization of Cosmetics Registration Act of 2022.On Dec. 29, 2022, in what has been called the ...

The Modernization of Cosmetics Regulation Act (MoCRA) introduces significant regulatory changes for the industry aimed at enhancing consumer safety.

Indeed, until the passage of the Modernization of Cosmetics Regulation Act, or MoCRA, in 2022, federal guidelines around the use of chemicals in the production of beauty products had not undergone ...

MoCRA's requirements are sure to present challenges to Florida beauty businesses, and it mandates that both the brand owner and the manufacturer of a cosmetics product are responsible for compliance.

The Modernization of Cosmetics Regulation Act of 2022, or MoCRA, is meant to unify and add transparency to those selling cosmetics in the U.S., protecting their users. An instance in which MoCRA ...

MoCRA has new, stringent requirements for Adverse Events reporting based on the FDA's medical device and drug adverse events reporting process including: ...

The compliance landscape for cosmetic products is now dramatically changing as a result of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which imposes significant compliance ...

Fulfilling MoCRA’s mandate—for the FDA to more closely monitor the cosmetics industry— will require resources, a lot of resources, for administrators, scientists assessing ingredient safety ...